Literature DB >> 4196288

Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections.

S B Halstead, J Casals, H Shotwell, N Palumbo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4196288     DOI： 10.4269/ajtmh.1973.22.365

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  22 in total

1.  Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.

Authors:  Leah C Katzelnick; Magelda Montoya; Lionel Gresh; Angel Balmaseda; Eva Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 2.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Authors:  Scott B Halstead
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

3.  Report of an NIAID workshop on dengue animal models.

Authors:  M Cristina Cassetti; Anna Durbin; Eva Harris; Rebeca Rico-Hesse; John Roehrig; Alan Rothman; Stephen Whitehead; Ramya Natarajan; Catherine Laughlin
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

Review 4.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

5.  Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

Authors:  William B Messer; Ruklanthi de Alwis; Boyd L Yount; Scott R Royal; Jeremy P Huynh; Scott A Smith; James E Crowe; Benjamin J Doranz; Kristen M Kahle; Jennifer M Pfaff; Laura J White; Carlos A Sariol; Aravinda M de Silva; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-02       Impact factor: 11.205

6.  The contribution of non-human primate models to the development of human vaccines.

Authors:  Tania Rivera-Hernandez; Diane G Carnathan; Peter M Moyle; Istvan Toth; Nicholas P West; Paul R Young; Guido Silvestri; Mark J Walker
Journal:  Discov Med       Date:  2014-12       Impact factor: 2.970

7.  Chemically induced temperature-sensitive mutants of dengue virus type 2: comparison of temperature sensitivity in vitro with infectivity suckling mice, hamsters, and rhesus monkeys.

Authors:  G C Tarr; A S Lubiniecki
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

8.  Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains.

Authors:  Nikos Vasilakis; Eric B Fokam; Christopher T Hanson; Ethan Weinberg; Amadou A Sall; Stephen S Whitehead; Kathryn A Hanley; Scott C Weaver
Journal:  Virology       Date:  2008-08-01       Impact factor: 3.616

9.  Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2.

Authors:  Lidice Bernardo; Alienys Izquierdo; Irina Prado; Delfina Rosario; Mayling Alvarez; Emidalys Santana; Jorge Castro; Rafael Martínez; Rosmari Rodríguez; Luis Morier; Gerardo Guillén; María G Guzmán
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

10.  A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus.

Authors:  Kanakatte Raviprakash; Danher Wang; Dan Ewing; David H Holman; Karla Block; Jan Woraratanadharm; Lan Chen; Curtis Hayes; John Y Dong; Kevin Porter
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.